Sex steroid levels in serum, myometrium, and fibromyomata in correlation with cytoplasmic receptors and 17β-HSD activity in different age-groups and phases of the menstrual cycle

Zusammenfassung Der Einfluß der Gewebekonzentrationen von Östradiol, Östron und Progesteron auf den Gehalt cytoplasmatischer Östradiol- und Progesteron-bindender Rezeptoren sowie der Enzymaktivität der 17β-Hydroxysteroiddehydrogenase (17β-HSD) im normalen Myometrium und Myomen während verschiedener reproduktiver Phasen der Frau wurde untersucht. Die gemessenen Parameter waren in ihren Konzentrationen von der endokrinen Situation abhängig. Die Gewebespiegel von Östradiol und Progesteron verhielten sich im normalen Myometrium während des mensuellen Cyclus ähnlich wie die Serumkonzentrationen. Die Östronspiegel des normalen Myometrium hingegen waren — im Vergleich zum Serum — in der lutealen Phase höher als in der follikulären. Die Östradiol-bindenden Rezeptoren wiesen ihre höchsten Konzentrationen im Cytoplasma in der proliferativen Cyclushälfte auf und fielen post ovulationem stark ab. Der Gehalt an cytoplasmatischen Progesteron-Rezeptoren war mittcyclisch am höchsten. Die enzymatische Aktivität der 17β-HSD stieg in der frühen Sekretionsphase etwa um das Zehnfache und korrelierte mit der Zunahme der Östron-Gewebespiegel. Die auffälligsten Unterschiede zwischen normalem Myometrium und Myom waren: niedrige Östron-Gewebespiegel und nur ein geringer Anstieg der 17β-HSD-Aktivität in der zweiten Cyclushälfte. Die cytoplasmatischen Rezeptorkonzentrationen für Östradiol und Progesteron waren während des Cyclus stets niedrig und zeigten keinerlei signifikante Schwankungen. Nach der Menopause entsprachen die Konzentrationen des cytoplasmatischen Östradiolrezeptor denen der follikulären Cyclusphase. Die Progesteron bindenden Rezeptorproteine sowie die 17β-HSD-Aktivität zeigten hingegen sehr niedrige Werte. Im Myometrium von Frauen, die hormonelle Kontrazeptiva nahmen, entsprachen die cytoplasmatischen Rezeptorkonzentrationen mittcyclischen Werten. Die 17β-HSD-Aktivität war trotz niedriger Progesteron-Gewebespiegel hoch. Summary A study has been made on the influence of estradiol, estrone, and progesterone on cytoplasmic estradiol and progesterone receptors and the 17β-hydroxysteroid dehydrogenase (17β-HSD) activity in normal myometrium and in fibromyomata during various phases of the menstrual cycle. The concentrations of estradiol, estrone, and progesterone in normal myometrium during the menstrual cycle were similar to those in serum except for higher levels of tissue estrone in the luteal phase. The number of estradiol-binding sites was highest during the proliferative phase and decreased after ovulation. The highest progesterone receptor content was found at midcycle. The 17β-HSD activity increased approximately 10-fold during the early secretory phase and correlated with the increase of tissue estrone levels. In fibromyomata there were low tissue estrone concentrations and only a moderate increase of 17β-HSD activity during the secretory phase. Furthermore, the number of cytoplasmic estradiol and progesterone receptor binding sites was low and did not change during the menstrual cycle, thus indicating in fibromyomata a defect in formation of cytoplasmic receptors, especially for progesterone. After the menopause the number of estradiol-binding sites was high, as in the proliferative phase of the cycle, whereas the number of progesterone-binding sites and the amount of 17β-HSD activity were extremely low. Myometrium from women on oral contraceptives showed an intermediate number of cytoplasmic receptors and a high 17β-HSD activity despite low tissue progesterone concentrations. Similar content being viewed by others References Schmidt-Gollwitzer, M.: Korrelation zwischen den Sexualsteroiden im Serum und im Endometrium, den Östradiol-und Progesteron-bindenden Rezeptorproteinen und der Aktivität der 17β-HSD während des mensuellen Zyklus. Habil.-Schr. Freie Univ. Berlin 1978 Schmidt-Gollwitzer, M., Eiletz, J., Genz, T., Pollow, K.: Determination of estradiol, estrone and progesterone in serum and myometrium, correlation with the content of sex steroid receptors and 17β-hydroxysteroid activity throughout menstrual cycle. J. Endocrinol. Metab.49, 370 (1979) Korenman, S. G.: Comparative binding affinity of estrogens and its relation to estrogenic potency. Steroids13, 163 (1969) Smith, H. E., Smith, R. G., Toft, D. O., Neergard, J. R., Burrows, E. P., O'Malley, B. W.: Binding of steroids to progesterone receptor proteins in chick oviduct and human uterus. J. Biol. Chem.249, 5924 (1974) Tseng, L., Gusberg, S. B., Gurpide, E.: Estradiol receptor and 17β-dehydrogenase in normal and abnormal endometrium. Ann. N.Y. Acad. Sci.286, 190 (1977) Farber, M., Conrad, S., Heinrichs, W. L., Herrmann, W. L.: Estradiol binding by fibroid tumors and normal myometrium. Obstet. Gynec.40, 479 (1972) Feil, P. D., Glasser, S. R., Toft, D. O., O'Malley, B. W.: Progesterone binding in the mouse and rat uterus. Endocrinology91, 738 (1972) Hsueh, A. J. W., Peck, E. J., Clark, J. H.: Progesterone antagonism of the estrogen receptor and estrogen-induced uterine growth. Nature254, 337 (1975) Kimball, F. A., Hansel, W.: Estrogen cytosol binding proteins in bovine endometrium and corpus luteum. Biol. Reprod.11, 566 (1974) Evans, E. H., Martin, J. D., Haehnel, R.: Estrogen receptor concentration in normal and pathological human uterine tissues. J. Clin. Endocrinol. Metab.38, 23 (1974) Tseng, L., Gurpide, E.: Changes in the in vitro metabolism of estradiol during the menstrual cycle. Am. J. Obstet. Gynecol.114, 1002 (1972) Bayard, F., Damilano, S., Robel, P., Baulieu, E.-E.: Cytoplasmic and nuclear estradiol and progesterone receptors in human endometrium. J. Clin. Endocrinol. Metab.46, 635 (1978) Bayard, F., Damilano, S., Robel, P., Baulieu, E.-E.: Recepteurs de l'oestradiol et de la progesterone dans l'endometre humain au cours du cycle menstruel. Ann. Endocrinol.2181, 1341 (1975) Illingworth, D. V., Wood, G. P., Flickinger, G. L., Mikhail, G.: Progesterone receptors of the human myometrium. J. Clin. Endocrinol. Metab.40, 1001 (1975) Rao, B. R., Wiest, W. G., Allen, W. M.: Progesterone “receptor” in human endometrium. Endocrinology95, 1275 (1974) Gorski, J., Sarff, M., Clark, J. H.: The regulation of uterine concentration of estrogen binding protein. Adv. Biosci.7, 5 (1971) Hai, M. T. V., Logeat, F., Warembourg, M., Milgrom, E.: Hormonal control of progesterone receptors. Ann. N.Y. Acad. Sci.286, 199 (1977) Noyes, R. W., Hertig, A. T., Rock, J.: Dating the endometrial biopsy. Fertil. Steril.1, 3 (1950) Scatchard, G.: The attraction of proteins for small molecules and ions. Ann. N.Y. Acad. Sci.51, 660 (1949) Pollow, K., Lübbert, H., Boquoi, E., Kreuzer, G., Jeske, R., Pollow, B.: Studies on 17β-hydroxysteroid dehydrogenase activity in human endometrium and endometrial carcinoma. 2. Characterization of the soluble enzyme from secretory endometrium. Acta Endocrinol. (Kbh.)79, 146 (1975) Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurement with the folin phenol reagent. J. Biol. Chem.193, 256 (1951) England, B. G., Niswender, G. D., Midgley, A. M.: Radioimmunoassay of estradiol-17β without chromatography. J. Clin. Endocrinol. Metab.38, 42 (1974) Hoffmann, B., Kyrein, H. J., Ender, M. L.: An efficient procedure for the determination of progesterone by radioimmunoassay applied to bovine peripheral plasma. Horm. Res.44, 302 (1973) Schmidt-Gollwitzer, M., Pachaly, J.: Radioimmunoassay Packet. Computer program. Freie Univ. Berlin 1974 Abraham, G. E.: Solid-phase radioimmunoassay of estradiol-17β. J. Clin. Endocrinol. Metab.29, 866 (1969) Rosen, V., Jung, J., Baulieu, E.-E., Robel, P.: Androgen binding proteins in human benign prostatic hypertrophy. J. Clin. Endocrinol. Metab.41, 761 (1975) Young, P. C. M., Cleary, R. E.: Characterization and properties of progesterone binding components in human endometrium. J. Clin. Endocrinol. Metab.39, 425 (1974) Philibert, D., Raynaud, J. P.: Binding of progesterone and R-5020, a highly potent progestin, to human endometrium and myometrium. Contraception10, 457 (1974) Raynaud, J. P.: R 5020, a tag for the progestin receptor. In: Progesterone receptors in normal and neoplastic tissues. McGuire, W. M., Raynaud, J. P., Baulieu, E.-E. (eds.), p. 9. New York: Raven Press 1977 Davies, I. J.: The measurement of cytoplasmic steroid “receptor” proteins. In: Molecular techniques and approaches in developmental biology. Chrispeel, M. J. (ed.), p. 39. New York: J. Wiley Sons 1973 Wagner, R. K.: Receptor assay in human target tissues. A critical assessment. Acta Endocrinol. [Suppl.] (Kbh.)193, 158 (1975) MacLaughlin, D. T., Richardson, G. S.: Progesterone binding by normal and abnormal human endometrium. J. Clin. Endocrinol. Metabol.42, 667 (1976) Baird, D. T., Guevara, A.: Concentration of unconjugated estrone and estradiol in peripheral plasma in nonpregnant women throughout the menstrual cycle, castrate and postmenopausal women and in men. J. Clin. Endocrinol. Metab.29, 149 (1969) Wiele, R. L. van de, Bogumil, J., Dyrenfurth, J., Ferin, M., Jewelewicz, R., Warren, M., Rizkallah, T., Mikhail, G.: Mechanisms regulating the menstrual cycle in women. Rec. Progr. Horm. Res.26, 63 (1970) Schmidt-Gollwitzer, M., Eiletz, J., Pachaly, J., Pollow, K.: Determination of estradiol, estrone, and progesterone in serum and human endometrium in correlation with the content of steroid receptors and 17β-hydroxysteroid dehydrogenase activity during the menstrual cycle. In: Radioimmunoassay and related procedures in medicine 1977, Vol. II. Vienna: International Atomic Energy Agency 1978 Runnebaum, B., Klinga, K., von Hoist, R., Junkermann, H.: Steroids in human myometrium and peripheral blood during the menstrual cycle. Am. J. Obstet. Gynecol.131, 628 (1978) Kontula, K.: Progesterone-binding protein in human myometrium. Binding site concentration in relation to endogenous progesterone and estradiol-17β levels. J. Steroid Biochem.6, 1555 (1975) Tseng, L., Gurpide, E.: Induction of human endometrial estradiol dehydrogenase. Endocrinology97, 825 (1975) Tseng, L., Gurpide, E.: Estradiol and 20a-dihydroprogesterone dehydrogenase activities in human endometrium during the menstrual cycle. Endocrinology94, 419 (1974) Pollow, K., Geilfuß, J., Boquoi, E., Pollow, B.: Estrogen and progesterone binding proteins in normal human myometrium and leiomyoma tissue. J. Clin. Chem. Clin. Biochem.16, 503 (1978) Daxenbichler, G., Grill, H. J., Wiesinger, H., Wittliff, J. L., Dapunt, O.: Quantity and molecular behaviour of estrogen and progesterone binding proteins in normal and neoplastic tissues of the human genital tract and in human mammary carcinoma. In: Multiple molecular forms of steroid hormone receptors. Agarwal, M. K. (ed.), p. 163. Amsterdam: Elsevier/North-Holland Biomedical Press 1977 Author information Authors and Affiliations Additional information This paper is dedicated to Prof. Dr. H. Lax on the occasion of his 70th birthday Rights and permissions About this article Cite this article Eiletz, J., Genz, T., Pollow, K. et al. Sex steroid levels in serum, myometrium, and fibromyomata in correlation with cytoplasmic receptors and 17β-HSD activity in different age-groups and phases of the menstrual cycle. Arch. Gynecol. 229, 13–28 (1980). https://doi.org/10.1007/BF02109824 Received: Issue date: DOI: https://doi.org/10.1007/BF02109824